Control of β-glucan exposure by the endo-1,3-glucanase Eng1 in Candida albicans modulates virulence
Mengli Yang(Hubei Engineering University), Haoping Liu(University of California, Irvine), Tingting Zhou(Second Military Medical University), Rachel Garleb(University of California, Irvine), Michaela Marshall(University of California, Irvine), Norma V. Solis(UCLA Medical Center), Daidong Wang(Amgen (United States)), Eric Pearlman(University of California, San Francisco), Marc Swidergall(Los Angeles Harbor College), Scott G. Filler(University of California, Los Angeles)
Cited by 63
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k
Guidelines for Treatment of Candidiasis
|Clinical Infectious Diseases|2004|1.4k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k